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     LKB1/AMPK is the main cellular energetic pathway, which acts as the sensor of 
various extra- and intracellular signals. In response to the signals, it regulates energy 
metabolism and the maintenance of cellular homeostasis, so its major role lies in the 
survival, growth and development of the whole organism. This pathway is of 
significant importance because it has the potential to suppress tumoral progress in the 
cell. Metformin, the widely used drug in the treatment of type 2 diabetes, exerts a 
significant antitumour activity. However, the direct mechanism of metformin´s action 
is still unknown. Metformin induces cellular stress similar to the metabolic stress via 
inhibiting mitochondrial respiratory chain complex I, which results in an increase of 
AMP levels in plasma. AMP then binds to the AMPKγ subunit, so metformin mediates 
the activation of AMPK. AMPK is suddenly phosphorylated on Thr172 of the AMPKα 
kinase domain via LKB1, which mediates the downregulation of many downstream 
kinases. The result is the regulation of the metabolism on the gene expression level. 
Catabolic processes (glycolysis, fatty acid oxidation) and autophagy are induced, and 
anabolic processes are inhibited. Metformin also reduces the expression of the main 
biotransformation genes of cytochrome P450 (CYP3A4, CYP2C9 and CYP2B6) via 
inhibition of the PXR nuclear receptor. Metformin disrupts the interaction of PXR with 
his coactivator SRC1, and impairs the function of PXR. In this study we have 
introduced the immunodetection method of Western blotting. Using specific 
antibodies, we detected the AMPKα phosphorylated form in the LS174T cell line 
derived from the human colon adenocarcinoma. The presence of the phosphorylated 
form correlates with the activation or inhibition of this kinase. Through the method of 
Western blotting we established that the model activators of AMPK, metformin and 
AICAR, increased the density of the bands for the phosphorylated form of AMPK, but 
did not increase for nonphosphorylated forms AMPKα and AMPKβ1/2. This gives 
evidence of the activation of the AMPK pathway in the LS174T cell line. Furthermore, 
the inhibitor of AMPK, the compound BML275, decreased the density of the band of 
the phosphorylated AMPKα. Thus, after further optimizing this method (e.g. 
optimizing titration concentrations and antibody dilutions, optimizing the optimal time 
of incubation with antibodies and the washing time) it will be possible to use this 
method for research purposes. We believe our analysis will contribute to the search for 
the metformin mechanism of action and will also contribute to the explanation of its 
effect on the expression of the biotransformation enzymes.
